Abstract
Original language | English |
---|---|
Pages (from-to) | 1283-1295 |
Number of pages | 13 |
Journal | Leukemia |
Volume | 36 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2022 |
Funding
Funding Information: We thank Jill Flewelling (Princess Margaret Cancer Centre) for administrative assistance and the Leukemia Tissue Bank (Princess Margaret Cancer Centre) for providing the primary AML samples. This work was supported by the Canadian Institutes of Health Research, the Ontario Institute for Cancer Research with funding provided by the Ontario Ministry of Research and Innovation, the Princess Margaret Cancer Centre Foundation, and the Ministry of Long-Term Health and Planning in the Province of Ontario. ADS holds the Ronald N. Buick Chair in Oncology Research. BN research is supported by the Israel Cancer Association Grant for outstanding research on behalf of G. Doron and the Israel Science Foundation physician-scientist Grant. Funding Information: We thank Jill Flewelling (Princess Margaret Cancer Centre) for administrative assistance and the Leukemia Tissue Bank (Princess Margaret Cancer Centre) for providing the primary AML samples. This work was supported by the Canadian Institutes of Health Research, the Ontario Institute for Cancer Research with funding provided by the Ontario Ministry of Research and Innovation, the Princess Margaret Cancer Centre Foundation, and the Ministry of Long-Term Health and Planning in the Province of Ontario. ADS holds the Ronald N. Buick Chair in Oncology Research. BN research is supported by the Israel Cancer Association Grant for outstanding research on behalf of G. Doron and the Israel Science Foundation physician-scientist Grant. Funding Information: ADS has received research funding from Takeda Pharmaceuticals and Medivir AB, and consulting fees/honorarium from Takeda, BMS, Novartis, Jazz, and Otsuka Pharmaceuticals. ADS is named on a patent application for the use of DNT cells to treat AML. Publisher Copyright: © 2022, The Author(s).
All Science Journal Classification (ASJC) codes
- Hematology
- Oncology
- Cancer Research